Skip to main content

Advertisement

SpringerLink
Log in

Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To assess efficacy and safety of percutaneous cryoablation (CA) for advanced and refractory extra-abdominal desmoid tumors.

Materials and methods

This retrospective study reviewed 30 consecutive patients with symptomatic desmoid tumors evolving after “wait and watch” periods, and despite medical treatment, treated by CA between 2007 and 2019. Progression free survival (PFS), objective response rate, pain reduction (decreased of visual analogic scale pain (VAS)\(\ge\) 3 or disappearance of pain), total volume lesion (TVL) and complications were documented.

Kaplan Meier method was used to outline PFS. Paired sample t test was used to compare volume of tumors before treatment and at 1 and 3 year.

Results

With a median follow-up of 18.5 months (range 6–93 months, interquartile range (IQR): 12–55), the PFS was 85.1% at 1 year and 77.3% at 3 years. Objective response was obtained for 80% of patients with a complete response for 43% patients. Pain reduction was obtained for 96.7% (95% confidence interval (95% CI): 90.3, 100) of patients.

Median volume of desmoid tumor before treatment was 124.1cm3 (range 2–1727cm3, IQR: 54–338cm3). Median change of TLV after ablation was 66.6% (95% CI: 37.2, 72.3; p = 0.002) at 1 year and 76.4% (95% CI: 59.1, 89.8; p = 0.002) at 3 year.

Adverse events rate was 36.6%, the most common was edema and temporary increase of pain in the days following CA. Four patients experienced a major complication (13.3%): 2 skin necrosis, 1 infection and 1 brachial plexopathy.

Conclusion

CA is an effective treatment for advanced and refractory extra-abdominal desmoid tumor, that induces durable responses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Reitamo JJ, Häyry P, Nykyri E, Saxén E (1982) The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673. https://doi.org/10.1093/ajcp/77.6.665

    Article  CAS  PubMed  Google Scholar 

  2. Nieuwenhuis MH, Casparie M, Mathus-Vliegen LMH et al (2011) A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer 129:256–261. https://doi.org/10.1002/ijc.25664

    Article  CAS  PubMed  Google Scholar 

  3. Fallen T, Wilson M, Morlan B, Lindor NM (2006) Desmoid tumors—a characterization of patients seen at Mayo Clinic 1976–1999. Fam Cancer 5:191–194. https://doi.org/10.1007/s10689-005-5959-5

    Article  PubMed  Google Scholar 

  4. Shields CJ, Winter DC, Kirwan WO, Redmond HP (2001) Desmoid tumours. Eur J Surg Oncol 27:701–706. https://doi.org/10.1053/ejso.2001.1169

    Article  CAS  PubMed  Google Scholar 

  5. Bertario L, Russo A, Sala P et al (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95:102–107. https://doi.org/10.1002/1097-0215(20010320)95:2%3c102::aid-ijc1018%3e3.0.co;2-8

    Article  CAS  PubMed  Google Scholar 

  6. Alman BA, Li C, Pajerski ME et al (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151:329–334

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Joglekar SB, Rose PS, Sim F et al (2011) Current perspectives on desmoid tumors: the Mayo clinic approach. Cancers 3:3143–3155. https://doi.org/10.3390/cancers3033143

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kasper B, Baumgarten C, Garcia J et al (2017) An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol Off J Eur Soc Med Oncol 28:2399–2408. https://doi.org/10.1093/annonc/mdx323

    Article  CAS  Google Scholar 

  9. Briand S, Barbier O, Biau D et al (2014) Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am 96:631–638. https://doi.org/10.2106/JBJS.M.00988

    Article  PubMed  Google Scholar 

  10. Toulmonde M, Pulido M, Ray-Coquard I et al (2019) Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Lancet Oncol 20:1263–1272. https://doi.org/10.1016/S1470-2045(19)30276-1

    Article  CAS  PubMed  Google Scholar 

  11. Gounder MM, Mahoney MR, Van Tine BA et al (2018) Sorafenib for advanced and refractory desmoid tumors. N Engl J Med 379:2417–2428. https://doi.org/10.1056/NEJMoa1805052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Teshima M, Iwae S, Hirayama Y, Furukawa T (2012) Nonsteroidal anti-inflammatory drug treatment for desmoid tumor recurrence after surgery. Otolaryngol-Head Neck Surg 147:978–979. https://doi.org/10.1177/0194599812453561

    Article  PubMed  Google Scholar 

  13. Kono T, Tomita I, Chisato N et al (2004) Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case. Dis Colon Rectum 47:246–249. https://doi.org/10.1007/s10350-003-0025-6

    Article  PubMed  Google Scholar 

  14. Skapek SX, Anderson JR, Hill DA et al (2013) Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children’s Oncology Group (COG) phase II study. Pediatr Blood Cancer 60:1108–1112. https://doi.org/10.1002/pbc.24457

    Article  CAS  PubMed  Google Scholar 

  15. Magalov Z, Shitzer A, Degani D (2007) Isothermal volume contours generated in a freezing gel by embedded cryo-needles with applications to cryo-surgery. Cryobiology 55:127–137. https://doi.org/10.1016/j.cryobiol.2007.06.009

    Article  CAS  PubMed  Google Scholar 

  16. Gangi A, Tsoumakidou G, Buy X, Quoix E (2010) Quality improvement guidelines for bone tumour management. Cardiovasc Intervent Radiol 33:706–713. https://doi.org/10.1007/s00270-009-9738-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Robinson D, Halperin N, Nevo Z (2001) Two freezing cycles ensure interface sterilization by cryosurgery during bone tumor resection. Cryobiology 43:4–10. https://doi.org/10.1006/cryo.2001.2312

    Article  CAS  PubMed  Google Scholar 

  18. Kurup AN, Schmit GD, Morris JM et al (2017) Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol 40:166–176. https://doi.org/10.1007/s00270-016-1487-y

    Article  PubMed  Google Scholar 

  19. Kurup AN, Morris JM, Schmit GD et al (2013) Neuroanatomic considerations in percutaneous tumor ablation. Radiographics 33:1195–1215

    Article  Google Scholar 

  20. Tsoumakidou G, Buy X, Garnon J et al (2011) Percutaneous thermal ablation: how to protect the surrounding organs. Tech Vasc Interv Radiol 14:170–176. https://doi.org/10.1053/j.tvir.2011.02.009

    Article  PubMed  Google Scholar 

  21. Tsoumakidou G, Garnon J, Ramamurthy N et al (2013) Interest of electrostimulation of peripheral motor nerves during percutaneous thermal ablation. Cardiovasc Intervent Radiol 36:1624–1628. https://doi.org/10.1007/s00270-013-0641-z

    Article  PubMed  Google Scholar 

  22. Kurtz J-E, Buy X, Deschamps F et al (2021) CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. Eur J Cancer 143:78–87. https://doi.org/10.1016/j.ejca.2020.10.035

    Article  CAS  PubMed  Google Scholar 

  23. U.S department of health and human services (2017) Common terminology criteria for adverse events (CTCAE), version 5.0

  24. Redifer Tremblay K, Lea WB, Neilson JC et al (2019) Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol 120:366–375. https://doi.org/10.1002/jso.25597

    Article  PubMed  PubMed Central  Google Scholar 

  25. Schmitz JJ, Schmit GD, Atwell TD et al (2016) Percutaneous cryoablation of extraabdominal desmoid tumors: a 10 year experience. Am J Roentgenol 207:190–195. https://doi.org/10.2214/AJR.15.14391

    Article  Google Scholar 

  26. Havez M, Lippa N, Al-Ammari S et al (2014) Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol 37:1500–1506. https://doi.org/10.1007/s00270-013-0830-9

    Article  CAS  PubMed  Google Scholar 

  27. Bouhamama A, Lame F, Mastier C et al (2019) Local control and analgesic efficacy of percutaneous cryoablation for desmoid tumors. Cardiovasc Intervent Radiol. https://doi.org/10.1007/s00270-019-02323-5

    Article  PubMed  Google Scholar 

  28. Kujak JL, Liu PT, Johnson GB, Callstrom MR (2010) Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol 39:175–182. https://doi.org/10.1007/s00256-009-0801-z

    Article  PubMed  Google Scholar 

  29. Alman B, Attia S, Baumgarten C et al (2020) The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 127:96–107. https://doi.org/10.1016/j.ejca.2019.11.013

    Article  Google Scholar 

  30. Slovak R, Ludwig JM, Gettinger SN et al (2017) Immuno-thermal ablations–boosting the anticancer immune response. J Immunother Cancer 5:78. https://doi.org/10.1186/s40425-017-0284-8

    Article  PubMed  PubMed Central  Google Scholar 

  31. Rozet I, Vavilala MS (2007) Risks and benefits of patient positioning during neurosurgical care. Anesthesiol Clin 25:631–653. https://doi.org/10.1016/j.anclin.2007.05.009

    Article  PubMed  PubMed Central  Google Scholar 

  32. Eastley N, McCulloch T, Esler C et al (2016) Extra-abdominal desmoid fibromatosis: a review of management, current guidance and unanswered questions. Eur J Surg Oncol EJSO 42:1071–1083. https://doi.org/10.1016/j.ejso.2016.02.012

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Imagerie Interventionnelle, Hôpitaux Universitaires de Strasbourg, 3 rue des Alisiers, 67100, Strasbourg, France

    Pierre Auloge, Julien Garnon, Joey Marie Robinson, Guillaume Koch, Jean Caudrelier, Julia Weiss, Roberto Luigi Cazzato & Afshin Gangi

  2. Service de Radiologie, Centre François Baclesse, Caen, France

    Marie-Aude Thenint

  3. Service d’Oncologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

    Jean Emmanuel Kurtz

Authors
  1. Pierre Auloge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julien Garnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joey Marie Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marie-Aude Thenint
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guillaume Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean Caudrelier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julia Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Roberto Luigi Cazzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jean Emmanuel Kurtz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Afshin Gangi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierre Auloge.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Institution from which the work originated: Imagerie interventionnelle, Nouvel Hôpital Civil, 1 place de l’hôpital, BP 426, 67,091 Strasbourg Cedex, France.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Auloge, P., Garnon, J., Robinson, J.M. et al. Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors. Int J Clin Oncol 26, 1147–1158 (2021). https://doi.org/10.1007/s10147-021-01887-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-021-01887-y

Search

Navigation